N. Scott Fine

Insider Reports History

Entity
Individual
Location
600 3 Rd Ave, New York, New York
Signature
/s/ N. Scott Fine
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by N. Scott Fine:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclo Therapeutics, Inc. Chief Executive Officer, Director Common Stock 744K $528K $0.71 Oct 20, 2023 Direct
Cyclo Therapeutics, Inc. Chief Executive Officer, Director Warrant to Purchase Common Stock 329K $41.2K $0.13 Oct 20, 2023 Direct
Cyclo Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 266K Jun 3, 2024 Direct

Insider Reports Filed by N. Scott Fine

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYTH Cyclo Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Oct 20, 2023 3 $175K 4 Oct 23, 2023 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Apr 20, 2023 2 $250K 4 Apr 24, 2023 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Mar 7, 2023 1 $0 4 Mar 9, 2023 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Feb 28, 2022 1 $0 4 Mar 2, 2022 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Feb 7, 2022 1 $37K 4 Feb 7, 2022 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Jan 19, 2022 1 $19.5K 4 Jan 19, 2022 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Dec 15, 2021 1 $19.5K 4 Dec 15, 2021 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Dec 2, 2021 1 $24.7K 4 Dec 2, 2021 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Nov 19, 2021 1 $26.3K 4 Nov 19, 2021 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Sep 15, 2021 1 $31.8K 4 Sep 15, 2021 Chief Executive Officer, Director
CYTH Cyclo Therapeutics, Inc. Aug 27, 2021 1 $0 4 Aug 30, 2021 Chief Executive Officer, Director